Canada purchases 500,000 human H5N1 vaccine doses

Canada purchased half a million doses of a human vaccine for high path avian flu. It is an effort to keep health risks at bay.

Last week an outbreak was reported in a backyard layer poultry farm in Canada.
One infectious disease expert warns with so many cases of seasonal flu popping up, it is likely the two viruses could mix. That would ultimately create a new virus.

According to Matthew Miller, “That process is how all prior flu pandemics, that we’re aware of in the past, have started. Two different influenza viruses infect one host. The avian flu might maintain the severe disease that it causes but gain the ability to spread well between humans the way that seasonal flu can.”

Canada’s Public Health Agency says that risks to the public are still low, but they warn that it is best to stay away from poultry flocks this flu season.

Related Stories
Record corn and sorghum crops boost feed grain supplies, while reduced soybean and cotton production tighten outlooks for oilseeds and fiber markets.
Food prices increased in December, but not as much as expected, according to the latest Consumer Price Index from the U.S. Bureau of Labor and Statistics.
Structural efficiency supports cattle prices and resilience — breaking it risks higher costs and greater volatility.
Market reaction was bearish for corn and soybeans, with analysts noting that abundant supplies amid tepid demand could keep price pressure on agricultural commodities.
Logistics capacity remains available, but winter volatility favors flexible delivery and marketing plans. NGFA President Mike Seyfert provides insight into grain transportation trends, trade policy, and priorities for the year ahead.
Rising adoption of GLP-1 drugs may gradually reshape food demand, with potential downstream effects on protein markets and consumer purchasing patterns.